0.10Open0.10Pre Close0 Volume46 Open Interest25.00Strike Price0.00Turnover6251.57%IV17.23%PremiumNov 8, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0926Delta0.0683Gamma214.10Leverage Ratio-162.9441Theta0.0000Rho19.82Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet